Since its inception in 1921, Science News has stood as an independent, nonprofit beacon, illuminating the complexities of scientific, medical,…
Read More
TWiV 1288: Clinical Update with Dr. Daniel Griffin
In a recent clinical update delivered by Dr. Daniel Griffin and Vincent Racaniello on the "This Week in Virology" (TWiV)…
Read More
Rubedo Life Sciences’ RLS-1496 Shows Promise in Treating Precancerous Skin Lesions with Minimal Irritation
For millions worldwide grappling with actinic keratoses (AK), the rough, scaly patches of sun-damaged skin that are precursors to squamous…
Read More
Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies
New research emerging from the Fralin Biomedical Research Institute at VTC is fundamentally questioning the established framework used to study…
Read More
Nigerian Researchers Unveil Water-in-Diesel Emulsion Technology as a Sustainable Path to Reducing Global Engine Emissions
The global industrial landscape remains heavily reliant on the diesel engine, a mechanical workhorse that powers the backbone of international…
Read More
Bocunebart’s PACAP-Targeting Mechanism Positions it as a Potential First-in-Class Therapy in a Thin Pipeline of Novel Late-Stage Candidates
New Data Unveiled for Bocunebart, a Promising Migraine Preventive Targeting a Novel Pathway Munich, Germany – June 29, 2026 –…
Read More
Real gulls attacked decoys with first-year colors less often those with adult colors
New research has revealed a fascinating insight into the social dynamics of American herring gulls, suggesting that their immature plumage…
Read More
Sea Anemones Employ a Counterintuitive Viral Defense, Revealing the Diverse Evolution of Animal Immunity
Scientists have uncovered a previously unknown and remarkably counterintuitive method by which sea anemones defend themselves against viral infections. This…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a critical initiative to accelerate the development of three investigational vaccines…
Read More
Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion
Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…
Read MoreYOU MAY HAVE MISSED
